DocWire News Editors

DocwireNews

<p>ASCO is in full swing this week in Chicago.&nbsp; Below are today&rsquo;s top headlines.&nbsp; <a href="https://www.docwirenews.com/asco-2019/">Check out even more here</a>.<h2 class="entry-title">Radiotherapy Versus Trans-Oral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma</h2><p>The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has increased, mainly related to a rise in human papillomavirus infection. Radiation therapy (RT) has historically been the standard treatment. However, trans-oral robotic surgery (TORS), a new surgical approach, has surpassed radiation therapy as the most common U.S. method due to the potential for fewer adverse events (AEs). A study presented at the 2019 ASCO Annual Meeting compared these treatment options and found that they had similar outcomes.</p><p><a href="https://www.docwirenews.com/conference-coverage/asco-2019/radiotherapy-versus-trans-oral-robotic-surgery-for-oropharyngeal-squamous-cell-carcinoma-2/">Read More Here</a></p><h2 class="entry-title">A New Standard of Care? Addition of Hormonotherapy to Radiotherapy Improves Survival in Prostate Cancer</h2><p>Following radical prostatectomy, radiotherapy is the standard salvage treatment. Researchers assessed the impact of adding short-term hormonotherapy to radiotherapy and found that this significantly improved 10-years metastatic free survival (MFS). The results of the randomized, open-label, phase III study were presented at the 2019 ASCO Annual Meeting.</p><p>A total of 743 patients were randomized 1:1 to receive radiotherapy (66 Gy/46 Gy) alone or in combination with goserelin for six months. Patients were stratified based on radiotherapy modality and risk group. Low-risk disease was defined as a Gleason score less than eight, surgical margins prostate-specific antigen doubling time greater than eight months, and no seminal vesicle involvement. Biological relapse was defined according to the American Society for Radiation Oncology consensus.</p><p><a href="https://www.docwirenews.com/conference-coverage/asco-2019/a-new-standard-of-care-addition-of-hormonotherapy-to-radiotherapy-improves-survival-in-prostate-cancer/">Read More Here</a></p><h3 class="entry-title">Systematic Differences in End-of-Life Care Observed in Centers Serving Minority Patients</h3><p>High-intensity treatment at end-of-life (EOL) is burdensome and considered low-quality care. Researchers assessed whether minority and white patients receive different quality of EOL care and found that there were systematic differences across U.S. cancer centers.</p><p>This retrospective cohort study included Medicare beneficiaries with poor-prognosis cancers who died between April 1, 2016, and December 31, 2016. Researchers attributed patients&rsquo; EOL treatment to the cancer center where they received the majority of inpatient services during the last six months of life.</p><p><a href="https://www.docwirenews.com/conference-coverage/asco-2019/systematic-differences-in-end-of-life-care-observed-in-centers-serving-minority-patients/">Read More Here</a></p><p><a href="https://www.docwirenews.com/asco-2019/">For more coverage click here</a></p></p>


Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Seldin Award Winner Advocates Online Education

Latest News

Today's Latest Oncology News Live from ASCO

ASCO 2019

ASCO is in full swing this week in Chicago.  Below are today's top headlines.  Check out even more here. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe